Charles Schwab Investment Management Inc. Grows Stock Holdings in The Clorox Company $CLX

Charles Schwab Investment Management Inc. grew its stake in The Clorox Company (NYSE:CLX) by 0.2% in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 754,524 shares of the company’s stock after purchasing an additional 1,538 shares during the period. Charles Schwab Investment Management Inc. owned approximately 0.61% of Clorox worth $90,596,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds and other institutional investors have also recently made changes to their positions in CLX. OVERSEA CHINESE BANKING Corp Ltd acquired a new stake in shares of Clorox in the 1st quarter worth $369,000. LPL Financial LLC increased its position in Clorox by 12.7% during the first quarter. LPL Financial LLC now owns 334,041 shares of the company’s stock worth $49,188,000 after purchasing an additional 37,538 shares during the last quarter. Mackenzie Financial Corp raised its stake in Clorox by 8.4% during the first quarter. Mackenzie Financial Corp now owns 14,597 shares of the company’s stock worth $2,149,000 after purchasing an additional 1,133 shares during the period. Vestcor Inc boosted its holdings in Clorox by 21.4% in the 1st quarter. Vestcor Inc now owns 5,181 shares of the company’s stock valued at $763,000 after purchasing an additional 914 shares during the last quarter. Finally, Baader Bank Aktiengesellschaft grew its stake in shares of Clorox by 24.9% in the 1st quarter. Baader Bank Aktiengesellschaft now owns 2,016 shares of the company’s stock valued at $296,000 after buying an additional 402 shares during the period. Institutional investors and hedge funds own 78.53% of the company’s stock.

Wall Street Analyst Weigh In

Several research firms have recently commented on CLX. Barclays reduced their price target on shares of Clorox from $112.00 to $108.00 and set an “underweight” rating on the stock in a research report on Tuesday, November 4th. Bank of America reduced their target price on Clorox from $135.00 to $125.00 and set a “neutral” rating on the stock in a research report on Wednesday, October 8th. Wells Fargo & Company decreased their price target on Clorox from $125.00 to $117.00 and set an “equal weight” rating on the stock in a research note on Tuesday, November 4th. Morgan Stanley lowered their price target on Clorox from $137.00 to $125.00 and set an “equal weight” rating for the company in a report on Tuesday, November 4th. Finally, TD Cowen reduced their price objective on shares of Clorox from $120.00 to $117.00 and set a “hold” rating on the stock in a report on Wednesday, October 1st. One research analyst has rated the stock with a Buy rating, twelve have assigned a Hold rating and five have assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, Clorox presently has a consensus rating of “Reduce” and a consensus target price of $125.69.

Insider Activity at Clorox

In other news, Director Pierre R. Breber acquired 4,000 shares of the company’s stock in a transaction on Friday, November 21st. The shares were bought at an average cost of $104.13 per share, with a total value of $416,520.00. Following the transaction, the director owned 13,000 shares in the company, valued at approximately $1,353,690. This trade represents a 44.44% increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, COO Eric H. Reynolds sold 15,041 shares of Clorox stock in a transaction on Thursday, September 4th. The stock was sold at an average price of $123.78, for a total transaction of $1,861,774.98. Following the sale, the chief operating officer directly owned 54,221 shares of the company’s stock, valued at approximately $6,711,475.38. This trade represents a 21.72% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders own 0.63% of the company’s stock.

Clorox Price Performance

CLX stock opened at $107.32 on Friday. The business’s fifty day moving average price is $113.61 and its 200 day moving average price is $121.36. The Clorox Company has a 12-month low of $98.20 and a 12-month high of $171.37. The company has a current ratio of 0.84, a quick ratio of 0.57 and a debt-to-equity ratio of 5.15. The company has a market capitalization of $13.09 billion, a PE ratio of 16.46, a P/E/G ratio of 0.92 and a beta of 0.52.

Clorox (NYSE:CLX) last released its earnings results on Monday, November 3rd. The company reported $0.85 earnings per share for the quarter, beating the consensus estimate of $0.78 by $0.07. The company had revenue of $1.43 billion during the quarter, compared to the consensus estimate of $1.41 billion. Clorox had a return on equity of 377.86% and a net margin of 11.40%.Clorox’s revenue was down 18.9% compared to the same quarter last year. During the same period in the previous year, the company posted $1.86 EPS. Clorox has set its FY 2026 guidance at 5.950-6.300 EPS. On average, sell-side analysts anticipate that The Clorox Company will post 7.15 EPS for the current year.

Clorox Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, February 13th. Stockholders of record on Wednesday, January 28th will be given a dividend of $1.24 per share. The ex-dividend date of this dividend is Wednesday, January 28th. This represents a $4.96 dividend on an annualized basis and a dividend yield of 4.6%. Clorox’s payout ratio is currently 77.86%.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.